ArticleNucleic acids research2026
Robust and generalizable CNV detection for single-cell sequencing assays.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Copy number variations (CNVs) are genomic structural variants that are strongly linked to cancer progression and genetic disorders. CNVs can be highly heterogeneous at population and tissue scale; thus, single-cell resolution detection holds great promise for studying clonal evolution and CNV-driven changes. Despite advanced sc-RNA-seq CNV detection methods, accurate methods for epigenomic single-cell modalities lag behind. We developed RIDDLER; a robust, unsupervised method that uses outlier-aware statistical modeling to detect CNVs across multiple single-cell modalities and assays. RIDDLER utilizes a robust regression framework to model the expected distribution of reads genome-wide by accounting for assay-specific biases, identifying CNVs as outliers from that distribution. This versatile framing allows deployment of RIDDLER in multiple modalities with appropriate bias features. We demonstrate the accuracy of RIDDLER in calling single-cell CNVs and dissecting clonal heterogeneity in sc-ATAC-seq and sc-methylation. RIDDLER is more accurate and more robust to data sparsity than competing methods. We illustrate useful applications of RIDDLER for dissection of clonal structure, identification of subclonal accessibility peaks, and multimodal integration from CNV structure. RIDDLER stands out as a scalable, generalizable multi-modal method for accurate CNV detection, empowering studies aiming to link CNV dynamics to epigenetic alterations within the same cell.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.